Pharmaceutical Commerce - April 2023

Click the title above for a link to open the Pharmaceutical Commerce April 2023 issue in an interactive PDF format.

DSCSA, 340B among the headliners at the Healthcare Distribution Alliance's Distribution Management Conference.

How various factors are affecting the amount of funds allocated to healthcare.

Innovation and investment in advancing lifesaving therapies for pediatric patients to the commercial stage remains a daunting task, but rapid advances today in modeling and simulation are reducing the hurdles for drugmakers.

As a November deadline looms for industry compliance with an interoperable system for product tracing, there is more urgency in the US pharma supply chain.

With the rapid rise of the specialty drug market, manufacturers are increasingly relying on new advances used by patient hubs to boost their levels of patient engagement.

Deciphering the different "technology-first” and “technology-enabled” patient support programs.

How personalized interventions can help boost the omnichannel experience for patient hubs—and drive engagement and impact adherence in outcomes.

Why deploying AI and analytics in tandem is a key targeting tool.